GENOME ANNOUNCEMENT
===================

In 2012, there were an estimated 8.6 million new cases of tuberculosis (TB) worldwide. In Peru, the incidence rate for TB was 95 cases/100,000 people, of which 96% of cases were drug-sensitive TB ([@B1]). It has been reported that in Peru there is a high diversity of *Mycobacterium tuberculosis* lineages, including Latin American-Mediterranean (LAM) (23.8%), Haarlem (23.8%), T (22.3%), and Beijing (9.3%) ([@B3]). We performed whole-genome sequencing and analysis to investigate the genetic diversity and phylogeny relationships of a drug-sensitive strain of *M. tuberculosis*, INS-SEN.

INS-SEN was isolated from Lima, Peru. The establishment of this strain's lineage was based on 24 mycobacterial interspersed repetitive unit-variable number of tandem repeat (MIRU-VNTR) loci ([@B4]) and by single-nucleotide polymorphisms (SNPs) based on phylogeny ([@B5]). The genomic DNA of INS-SEN was sequenced to 1,406× coverage, which consisted of 61,422,158 paired-end reads, using the Illumina HiSeq 2000 sequencer machine. Then, the genomic sequence was assembled with BWA v 0.5.9-r16 ([@B6]), using the H37Rv genome (AL123456.3) as a reference, producing 18 contigs. The genomic sequence was annotated with the Rapid Annotations using Subsystem Technology (RAST) server ([@B7]) and Prokaryotic Genome Annotation Pipeline (PGAAP). A polymorphism study of the INS-SEN genome was carried out by comparative analysis against the genome of the drug-sensitive strain KZN 4207 (LAM lineage) ([@B8]) using SNPsFinder ([@B9]) to identify the differences between intergenic and coding regions, and then clusters of orthologous groups (COG) ([@B10]).

The 24 loci for MIRU-VNTR and SNPs based on phylogeny determined that INS-SEN belongs to the LAM lineage. The genome sequence is about 99.98% completed compared to the H37Rv reference genome, which has a genome size of 4.42 Mb. The INS-SEN strain has a total of 4,383,671 bp, with an average GC content of 65.6%. It contains 4,389 predicted coding sequences (CDSs). A total of 499 polymorphisms were observed in our comparative study, with 440 of these located in the coding regions of the genome that were classified in the following COG categories: secondary metabolite biosynthesis, transport, and catabolism (Q) (*n* = 38); lipid transport and metabolism (I) (*n* = 35); replication, recombination, and repair (L) (*n* = 34); energy production and conversion (C) (*n* = 32); amino acid transport and metabolism (E) (*n* = 31); carbohydrate transport and metabolism (G) (*n* = 27); cell motility (N) (*n* = 26); cell wall/membrane/envelope biogenesis (M) (*n* = 24); coenzyme transport and metabolism (H) (*n* = 23); signal transduction mechanisms (T) (*n* = 21); inorganic ion transport and metabolism (P) (*n* = 21); transcription (K) (*n* = 17); translation, ribosomal structure, and biogenesis (*n* = 14); posttranslational modification, protein turnover, and chaperones (*n* = 13); nucleotide transport and metabolism (*n* = 12); defense mechanisms (*n* = 7); cell cycle control, cell division, and chromosome partitioning (*n* = 7); RNA processing and modification (*n* = 2); and intracellular trafficking, secretion, and vesicular transport (*n* = 2).

INS-SEN had more SNPs in PPE associated with antigenic variation ([@B11]) in category N and in PE-PGRS associated with antigenic variation and immune evasion ([@B12]) in category M than the strains KZN 4207 and H37Rv. Additionally, INS-SEN showed more mutations in category Q than the strain KZN 4207. It is possible that the organization of SNPs in INS-SEN may have a role in adaptation to its environment.

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number [JAQH00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=JAQH00000000). The version described in this paper is JAQH01000000.
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